Tennessee Valley Healthcare System

Nashville, Tennessee 37232

1 studies enrolling now · 3 studies all time

What they study most

Dyslipidemia, Multiple Myeloma, Renal Cell Carcinoma, Type2 Diabetes

Studies at this site

• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer — Completed